Tirzepatide 10 mg/0 — Class I drug recall D-0511-2024
Ongoing recall by Revive Rx LLC dba Revive Rx Pharmacy, reported 2024-06-05, distributed nationwide. Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
| Recall number | D-0511-2024 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Revive Rx LLC dba Revive Rx Pharmacy, Houston, TX, United States |
| Recall initiated | 2024-04-20 |
| Classified | 2024-05-29 |
| Reported by FDA | 2024-06-05 |
| Distributed | Nationwide (US) |
| Quantity | 751 vials |
| Reason classes | labeling |
| NDC | 99000-9278-64 |
| Lot numbers | 748127 |
| Expiration dates | 2024-09-24 |
Product
Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64
Reason for recall
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0511-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.